ADMA Biologics Inc (ADMA) — Net Asset Quality Index
ADMA Biologics Inc (ADMA) has a Net Asset Quality Index of 59.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $684.21 Million minus total liabilities of $276.00 Million yields net assets of $408.21 Million. A higher index indicates a stronger, lower-leverage balance sheet. Read how much debt does ADMA Biologics Inc carry for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
ADMA Biologics Inc Net Asset Quality Index Over Time (2006–2025)
This chart shows how ADMA Biologics Inc's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of June 2026, the index stands at 59.7%, representing net assets of $408.21 Million against total assets of $684.21 Million USD. For live market cap and overall valuation, see ADMA Biologics Inc (ADMA) total market value.
Annual Net Asset Quality Index for ADMA Biologics Inc (2006–2025)
The table below presents the year-by-year Net Asset Quality Index for ADMA Biologics Inc from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check ADMA strategic asset allocation to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 76.5% | $477.32 Million | $624.24 Million | $146.92 Million | ▲ +5.0 pp |
| 2024 | 71.4% | $349.02 Million | $488.68 Million | $139.66 Million | ▲ +30.3 pp |
| 2023 | 41.1% | $135.21 Million | $329.18 Million | $193.98 Million | ▼ -2.5 pp |
| 2022 | 43.6% | $151.97 Million | $348.46 Million | $196.49 Million | ▼ -7.5 pp |
| 2021 | 51.1% | $141.17 Million | $276.25 Million | $135.08 Million | ▲ +8.6 pp |
| 2020 | 42.5% | $88.25 Million | $207.67 Million | $119.42 Million | ▲ +21.9 pp |
| 2019 | 20.6% | $26.19 Million | $127.09 Million | $100.90 Million | ▼ -1.6 pp |
| 2018 | 22.2% | $19.77 Million | $88.88 Million | $69.11 Million | ▼ -15.1 pp |
| 2017 | 37.3% | $40.33 Million | $108.02 Million | $67.69 Million | ▲ +56.2 pp |
| 2016 | -18.8% | $-4.46 Million | $23.69 Million | $28.14 Million | ▼ -22.3 pp |
| 2015 | 3.5% | $820.97K | $23.71 Million | $22.89 Million | ▼ -18.6 pp |
| 2014 | 22.1% | $6.01 Million | $27.23 Million | $21.22 Million | ▼ -45.4 pp |
| 2013 | 67.5% | $21.57 Million | $31.98 Million | $10.41 Million | ▲ +6.9 pp |
| 2012 | 60.6% | $9.42 Million | $15.56 Million | $6.13 Million | ▲ +26.3 pp |
| 2011 | 34.3% | $2.77K | $8.08K | $5.31K | ▲ +37.2 pp |
| 2010 | -2.9% | $-346.00 | $12.01K | $12.36K | ▼ -2.9 pp |
| 2009 | 0.0% | $0.00 | $8.69 Million | $8.69 Million | ▲ +0.0 pp |
| 2008 | 0.0% | $0.00 | $2.65 Million | $2.65 Million | ▲ +0.0 pp |
| 2007 | 0.0% | $0.00 | $14.65 Million | $14.65 Million | ▲ +0.0 pp |
| 2006 | 0.0% | $0.00 | $14.65 Million | $14.65 Million | — |